Takeda Pharmaceutical Company Limited (“Takeda”) congratulates Kyoto University's Professor Tasuku Honjo on the winning of Nobel Prize in Physiology or Medicine. Prof. Honjo's revolutionary discovery is cementing as a drug innovation platform. We hope that this discovery born in Japan will further bring about innovative medicines that will benefit patients worldwide.
Since 2015, Takeda has committed to collaborate with Center for iPS Cell Research Application (CiRA) of Kyoto University. This extensive 10-year collaboration is intended to develop clinical applications of iPS cells from Japan. It is our hope to deliver innovative treatments that meet patient needs as soon as possible through collaborating with academia in Japan.